ABT stock: buy or sell?

ABT stock price: $84.37 -0.62% At close on August 22nd, 2019

Updated on:
August 22nd, 2019


Abbott Laboratories shares slightly fell -0.62% to $84.37 today.

Should I buy ABT stock?

Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. That's why is so important to choose your own trading strategy that matches with your character as inversor. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.

None of our preferred buy setups matches with Abbott Laboratories stock situation right now, hence this is not a suitable entry point.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This doesn't mean ABT will fall in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems.

Is Abbott Laboratories stock a buy?

Financial institutions and banks publish stock ratings everyday. At Stocks2.com, we collected 15 ratings published for ABT stock in the last 30 days.

The general sentiment of these ratings is bullish for ABT stock, with 12 positive ratings.
Is ABT a good stock to buy?
DateAnalyst / BrokerPrevious ratingCurrent rating
2019-8-14Canaccord GenuityHoldBuy
2019-8-14BMO Capital Marketsn/an/a
2019-7-18Raymond Jamesn/aOutperform
2019-7-18Jefferies Financial Groupn/aBuy
2019-7-18BMO Capital Marketsn/aOutperform
2019-7-16Morgan Stanleyn/aOverweight
2019-6-13Wells Fargo & Con/aOutperform
2019-6-13Bank of American/aBuy
2019-4-15Royal Bank of Canadan/aBuy
2019-3-14Wells Fargo & Con/aBuy
2019-2-7Bank of AmericaBuyBuy
2019-1-24BTIG Researchn/aHold
2019-1-2Morgan StanleyOverweightOverweight

ABT stock analysis

Daily outlook

Shares of Abbott Laboratories closed today at $84.37 and slightly fell an ugly -0.62%.

Shares of Abbott Laboratories closed today at $84.37 and slightly fell an ugly -0.62%. ABT is soaring again after a 4.11% correction from its last top on Aug 13th at $87.10. Since June when ABT stock price broke up the SMA100d line, it gained $8.94 (11.85%). On Jul/23, ABT hit a new all time high, pushing higher than on July 22nd tops. Check different trading setups that use ATHs as triggers.

ABT stock chart (daily)

Weekly outlook

Abbott Laboratories declined an unpleasant -0.48% this week.

ABT shows a long term strength with several rising tops and rising bottoms. It left a new bottom at $82.31 early August. Previous top ($88.76) will play as a resistance in possible new gains. Not so far away is the last price record Abbott Laboratories marked late July. Since early June when ABT stock price broke up the SMA20w line, it gained $8.52 (11.23%).

ABT stock chart (weekly)

ABT stock price history

ABT stock went public on March 17th, 1980 with a price of $0.201. Since then, ABT stock surged a 42,085.00%, with a yearly average of 1,079.10%. If you had invested $1,000 in ABT stock in 1980, it would worth $420,850.00 today.

1: Adjusted price after possible price splits or reverse-splits.

ABT stock historical price chart

ABT stock reached all-time highs on July 23rd with a price of $88.76.

ABT stock price target is $90.20

Nobody can reliably foresee how stock prices may evolve in the future. However, many stock price predictions are published every day by banks, financial institutions and independent analysts. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. We have 11 price forecasts for ABT stock released in the last 30 days:
ABT stock price predictions
DateAnalyst / BrokerActionPrevious targetCurrent targetDiff
2019-7-18Raymond JamesRaises Target$87.00$93.006.9%
2019-7-18Jefferies Financial GroupRaises Target$80.00$98.0022.5%
2019-7-18BMO Capital MarketsRaises Targetn/a$94.00-
2019-7-16Morgan StanleyRaises Target$85.00$93.009.4%
2019-6-13Wells Fargo & CoRaises Target$89.00$91.002.2%
2019-6-13Bank of AmericaRaises Target$81.00$90.0011.1%
2019-4-15Royal Bank of CanadaRaises Targetn/a$82.00-
2019-2-7Bank of AmericaReiterates$73.00$81.0011%
2019-1-25ArgusRaises Targetn/a$90.00-
2019-1-2Morgan StanleyRaises Target$82.00$85.003.7%
(in average)$82.90$90.209.0%
Moving in a range from $98.00 and $81.00, the price forecast for ABT stock is $90.20. In average, analysts' outlook on ABT price forecast is positive, improving the forecast by a 9.00% from previous estimations.

Financials and fundamental analysis

Earnings date and Earnings per Share

Since April, when Abbott Laboratories posted its last earnings report, it escalated a more than good 9.27%. Unfortunately, reported EPS is not yet available in our database.
ABT earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise

Annual financial results

In 2018, Abbott Laboratories annual sales rocketed a cool 11.64% to $30,578.00 million dollars from $27,390.00 marked in 2017. In contrast, its earnings margin (compared to sales) escalated to 7.74%, that is $2,368.00 million.

Abbott Laboratories presents anual results in December, and to compare its evolution since then, we estimate annual sales and income figures by adding results from the last 4 quarters. This is called TTM (or Twelve Trailing Months). So, Abbott Laboratories TTM sales up to March 2019 were $30,723.00 and earnings $2,622.00 million USD. If we compare this TTM figures with the last reported annuality, we can review Abbott Laboratories business evolution since December 2018: Annual revenues up to March, compared to lastest yearly report, stayed steady a tight 0.47%. In line, profit margin (net income/sales) remained stable at 7.74%.

ABT annual Sales and Income evolution
2013$19,660 M-$1,970 M10.0%-
2014$20,247 M2.99%$2,284 M11.3%15.94%
2015$20,405 M0.78%$4,423 M21.7%93.65%
2016$20,853 M2.20%$1,400 M6.7%-68.35%
2017$27,390 M31.35%$477 M1.7%-65.93%
2018$30,578 M11.64%$2,368 M7.7%396.44%
TTM $30,723 M0.47%$2,622 M8.5%10.73%

Quarterly financial results

Abbott Laboratories posted $7,535.00 million in sales for 2019-Q1, a -2.96% less compared to previous quarter. Reported quarter income marked $672.00 M with a profit margin of 8.92%. Profit margin stayed steady a 0.50% compared to previous quarter when profit margin was 8.42%. When comparing sales to same quarter last year, Abbott Laboratories sales marked a slightly fine growth and stepped up a 1.96%.
ABT quarterly Sales and Income evolution
2017-Q2$6,640 M-$269 M4.1%-
2017-Q3$6,830 M2.86%$558 M8.2%107.43%
2017-Q4$7,589 M11.11%$-828 M-10.9%-248.39%
2018-Q1$7,390 M-2.62%$418 M5.7%-150.48%
2018-Q2$7,767 M5.10%$733 M9.4%75.36%
2018-Q3$7,656 M-1.43%$563 M7.4%-23.19%
2018-Q4$7,765 M1.42%$654 M8.4%16.16%
2019-Q1$7,535 M-2.96%$672 M8.9%2.75%

Abbott Laboratories ownership

When you are planning to buy shares of a stock, it's worth to check its ownership structure.

Abbott Laboratories shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 0.72% of all shares.

In case of Abbott Laboratories stock, 76.49% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for ABT stock account 0.00%, no big difference from last month.

For a better understanding, the next table shows ownership data compared to other related stocks:

Market cap$148.5 B$78.0 B$59.3 B$13.5 B$349.9 B
Total shares1,760.0 M1,630.0 M1,390.0 M268.1 M2,660.0 M
Float shares1,750.0 M1,630.0 M1,390.0 M266.1 M2,630.0 M
  - Institutional holdings (%)76.5%75.0%93.4%99.7%69.2%
  - Insider holdings (%)0.7%0.1%0.2%0.3%0.1%
Shares in short selling0.0%0.0%0.0%0.0%0.0%

ABT summary

Thursday, August 22nd, 2019
Day range$83.64 - $85.30
Previous close$84.90
Session gain-0.62%
Average true range$1.90
50d mov avg$85.14
100d mov avg$81.16
200d mov avg$76.74
Daily patternlb01a
Weekly pattern lb03a

Abbott Laboratories performance

Performance as an absolute value is never valid if it's not benchmarked against competitors or related stocks in the industry. We picked Bristol-Myers Squibb, Boston Scientific, Hologic, , Medtronic, Mylan, Pfizer and Thermo Fisher Scientific as the bechmarking frame for Abbott Laboratories stock.
BMYBristol-Myers Squ...3.15%-4.45%-17.61%
BSXBoston Scientific10.92%5.31%22.90%
TMOThermo Fisher Sci...2.41%10.49%18.85%

Abbott Laboratories competitors

We selected a few stocks to conform a list of Abbott Laboratories competitors to watch if you are interested in investing in ABT:

Latest ABT stock news